These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7130745)

  • 41. Role of hair follicles in the repigmentation of vitiligo.
    Cui J; Shen LY; Wang GC
    J Invest Dermatol; 1991 Sep; 97(3):410-6. PubMed ID: 1714927
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Spectrophotometer is useful for assessing vitiligo and chemical leukoderma severity by quantifying color difference with surrounding normally pigmented skin.
    Hayashi M; Okamura K; Araki Y; Suzuki M; Tanaka T; Abe Y; Nakano S; Yoshizawa J; Hozumi Y; Inoie M; Suzuki T
    Skin Res Technol; 2018 May; 24(2):175-179. PubMed ID: 29057565
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Abnormal histological findings in active vitiligo include the normal-appearing skin.
    Pretti Aslanian FM; Noé RA; Cuzzi T; Filgueira AL
    Pigment Cell Res; 2007 Apr; 20(2):144-5. PubMed ID: 17371442
    [No Abstract]   [Full Text] [Related]  

  • 44. Growth defects of melanocytes in culture from vitiligo subjects are spontaneously corrected in vivo in repigmenting subjects and can be partially corrected by the addition of fibroblast-derived growth factors in vitro.
    Puri N; Mojamdar M; Ramaiah A
    Arch Dermatol Res; 1989; 281(3):178-84. PubMed ID: 2774645
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structural aberration of the rough endoplasmic reticulum and melanosome compartmentalization in long-term cultures of melanocytes from vitiligo patients.
    Boissy RE; Liu YY; Medrano EE; Nordlund JJ
    J Invest Dermatol; 1991 Sep; 97(3):395-404. PubMed ID: 1875040
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Depletion and repopulation of Langerhans cells in nonsegmental type vitiligo.
    Kao CH; Yu HS
    J Dermatol; 1990 May; 17(5):287-96. PubMed ID: 2380433
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Autologous epidermal grafting with PUVA-irradiated donor skin for the treatment of vitiligo.
    Lee AY; Jang JH
    Int J Dermatol; 1998 Jul; 37(7):551-4. PubMed ID: 9679700
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo.
    Gauthier Y; Cario-Andre M; Lepreux S; Pain C; Taïeb A
    Br J Dermatol; 2003 Jan; 148(1):95-101. PubMed ID: 12534601
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation.
    Le Poole IC; van den Wijngaard RM; Westerhof W; Dutrieux RP; Das PK
    J Invest Dermatol; 1993 Jun; 100(6):816-22. PubMed ID: 7684427
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expansion of vitiligo lesions is associated with reduced epidermal CDw60 expression and increased expression of HLA-DR in perilesional skin.
    Le Poole IC; Stennett LS; Bonish BK; Dee L; Robinson JK; Hernandez C; Hann SK; Nickoloff BJ
    Br J Dermatol; 2003 Oct; 149(4):739-48. PubMed ID: 14616364
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term follow-up of leucoderma patients treated with transplants of autologous cultured melanocytes, ultrathin epidermal sheets and basal cell layer suspension.
    Olsson MJ; Juhlin L
    Br J Dermatol; 2002 Nov; 147(5):893-904. PubMed ID: 12410698
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical markers of vitiligo activity.
    Benzekri L; Gauthier Y
    J Am Acad Dermatol; 2017 May; 76(5):856-862. PubMed ID: 28245942
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Eruptive facial lentiginosis-like repigmentation in a patient with longstanding generalized vitiligo without a detectable trigger.
    Kaiser D; Hosta V; Loubser J; Pavlović MD
    Acta Dermatovenerol Alp Pannonica Adriat; 2022 Mar; 31(Suppl):S25-S26. PubMed ID: 35339139
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Ultrastructural changes of epidermal calcium gradient and lipid lamellar membrane in depigmented skin lesions of vitiligo patients].
    Liu ZZ; Lei TC
    Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(14):1108-11. PubMed ID: 27095778
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased monoamine oxidase A activity in the epidermis of patients with vitiligo.
    Schallreuter KU; Wood JM; Pittelkow MR; Buttner G; Swanson N; Korner C; Ehrke C
    Arch Dermatol Res; 1996; 288(1):14-8. PubMed ID: 8750929
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inflammatory changes in vitiligo: stage I and II depigmentation.
    Sharquie KE; Mehenna SH; Naji AA; Al-Azzawi H
    Am J Dermatopathol; 2004 Apr; 26(2):108-12. PubMed ID: 15024191
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Keratinocyte cultures from involved skin in vitiligo patients show an impaired in vitro behaviour.
    Bondanza S; Maurelli R; Paterna P; Migliore E; Giacomo FD; Primavera G; Paionni E; Dellambra E; Guerra L
    Pigment Cell Res; 2007 Aug; 20(4):288-300. PubMed ID: 17630962
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vitiligo: characterization of melanocytes in repigmented skin after punch grafting.
    Kovacs D; Abdel-Raouf H; Al-Khayyat M; Abdel-Azeem E; Hanna MR; Cota C; Picardo M; Anbar TS
    J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):581-90. PubMed ID: 25089006
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical, histopathological and ultrastructural characteristics of naevus depigmentosus.
    Xu AE; Huang B; Li YW; Wang P; Shen H
    Clin Exp Dermatol; 2008 Jul; 33(4):400-5. PubMed ID: 18355354
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparative study of mitochondrial ultrastructure in melanocytes from perilesional vitiligo skin and perilesional halo nevi skin.
    Ding GZ; Zhao WE; Li X; Gong QL; Lu Y
    Arch Dermatol Res; 2015 Apr; 307(3):281-9. PubMed ID: 25672813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.